logo-loader

Anavex Life Sciences advancing its Parkinson's disease therapy through the pipeline

Published: 00:13 13 Feb 2019 GMT

Anavex Life Sciences Corp (NASDAQ:AVXL) President and CEO Christopher Missling sat down with Proactive Investors at the BIO CEO & Investor Conference in New York.

The biopharmaceutical company is developing therapeutics to treat neurodegenerative and neurodevelopmental diseases including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system diseases, pain, and various types of cancer.

Oriole Resources outlines 2023 achievements and future exploration plans

Oriole Resources PLC (AIM:ORR) CEO Tim Livesey and chief financial officer Bob Smeeton join Proactive's Stephen Gunnion with details of the company's 2023 financial and operational performance. Livesey highlighted successful exploration programs in Cameroon, at the Bibemi and Mbe projects,...

4 minutes ago